March 15: CellASIC awarded NIH "Lab to Marketplace" SBIR grant
CellASIC received a Small Business Innovation Research (SBIR) award from the National Institutes of Health to continue advancing its state-of-the-art microfluidics product development. Specifically, this grant will be used to complete a microfluidic liver array system for studying drug metabolism properties in vitro. This is critically important for biopharmaceutical advancement to avoid liver related injury in clinical testing and post-marketing. The SBIR funding will also allow CellASIC to further improve its industry leading microfabrication facilities to attain higher product quality, throughput, and yield.
CellASIC's innovative microfluidic cell culture products will be showcased at the Laboratory Automation exhibit hall, as well as a presentation on "Microfluidic Cell Culture Arrays."